How to Optimize Your T Cell Therapy Workflow—Without the Use of Serum or Feeder Cells
In this talk, Dr. Dominika Nackiewicz introduces how STEMCELL Technologies can help optimize your T cell cultures with robust, high-performance products and expert support. You will learn how to generate high yields of functional T cells for cell therapy development and manufacturing using the new GMP ImmunoCult™ medium and activators. She will also discuss efficient gene editing strategies using the new CellPore™ Transfection System and solutions for T cell generation from pluripotent stem cells or hematopoietic stem and progenitor cells.
This webinar is part of the “Translational T Cell Talks: Scaling for the Future” event hosted in collaboration with Scientist.com on June 11, 2024. View the rest of the talks and read the Q&A transcripts.
Developing safe and efficacious T cell therapies requires a wide range of reliable tools and technologies. To avoid costly delays and ensure a smoother transition from bench-to-bedside, scientists need standardized reagents for their T cell cultures.
In this talk, Dr. Dominika Nackiewicz introduces how STEMCELL Technologies can help optimize your T cell cultures with robust, high-performance products and expert support. You will learn how to generate high yields of functional T cells for cell therapy development and manufacturing using the new GMP ImmunoCult™ medium and activators. She will also discuss efficient gene editing strategies using the new CellPore™ Transfection System and solutions for T cell generation from pluripotent stem cells or hematopoietic stem and progenitor cells.
This webinar is part of the “Translational T Cell Talks: Scaling for the Future” event hosted in collaboration with Scientist.com on June 11, 2024. View the rest of the talks and read the Q&A transcripts.
In this talk, Dr. Dominika Nackiewicz introduces how STEMCELL Technologies can help optimize your T cell cultures with robust, high-performance products and expert support. You will learn how to generate high yields of functional T cells for cell therapy development and manufacturing using the new GMP ImmunoCult™ medium and activators. She will also discuss efficient gene editing strategies using the new CellPore™ Transfection System and solutions for T cell generation from pluripotent stem cells or hematopoietic stem and progenitor cells.
This webinar is part of the “Translational T Cell Talks: Scaling for the Future” event hosted in collaboration with Scientist.com on June 11, 2024. View the rest of the talks and read the Q&A transcripts.
Publish Date:
August 27, 2024
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
Next-Generation Cell Isolation Solutions for T Cell Therapy Research
Publish Date: August 26, 2024 -
Advances in Point-of-Care Cell Engineering—What Are You Feeding Your CAR T Cells?
Publish Date: August 27, 2024 -
Roundtable: Improving Collaboration Between Industry and Academia in the Field of CAR T Cell Therapy
Publish Date: August 27, 2024
Explore Our Products
-
Magnet for large-scale immunomagnetic separation -
EasySep™ Human T Cell Isolation Kit
8-Minute cell isolation kit using immunomagnetic negative selection -
cGMP, serum-free, and xeno-free medium for the expansion of human T cells
